D-1499-2016 Class II Terminated

Recalled by Aurobindo Pharma USA Inc — Plainsboro, NJ

FDA drug recall D-1499-2016 was initiated by Aurobindo Pharma USA Inc on Aug 3, 2016 and is designated Class II. Reason for recall: Presence of Foreign Tablets/Capsules: Firm received a market complaint stating the presence of one foreign tablet (Montelukast Sodium Chewable Tab 4mg) in the product bottle of Pantoprazole. The recall status is terminated (terminated Jun 8, 2018). Affected quantity: 23016 bottles.

Recall details

Product Type
Drugs
Report Date
Sep 21, 2016
Initiation Date
Aug 3, 2016
Termination Date
Jun 8, 2018
Voluntary/Mandated
Voluntary: Firm initiated
Product Quantity
23016 bottles

Product description

Pantoprazole Sodium Delayed-Release Tablets USP, 40 mg Rx Only, 90 tablets per bottle, Manufactured for Aurobindo Pharma USA, Inc 2400 Route 130 North Dayton, NJ 08810, Manufactured by: Aurobindo Pharma Limited Unit-VII (SE2), Mahaboob Nagar (Dt) - 509302, India , NDC 65862-0560-90

Reason for recall

Presence of Foreign Tablets/Capsules: Firm received a market complaint stating the presence of one foreign tablet (Montelukast Sodium Chewable Tab 4mg) in the product bottle of Pantoprazole.

Distribution pattern

CA

Code information

PSSB16011-A, Exp 01/18

Source

Dataset
openFDA drug recall enforcement reports
FDA record
This recall in openFDA (JSON)
Enforcement Report
Search FDA's Enforcement Report for D-1499-2016
openFDA file date
Nov 16, 2026
Loaded by RegDataLab
Nov 17, 2026

These dates say when openFDA published the data file and when RegDataLab last loaded it.

Source: openFDA record for D-1499-2016. Report a data issue: hello@regdatalab.com.